Johnson & Johnson has been ordered to pay $55m (£37.7m) in the latest legal fight over claims that its talc-based powder causes cancer.
A St Louis jury handed down the verdict after deliberating for eight hours on Monday.
It comes after a jury awarded $72m in February to the family of a woman whose death from ovarian cancer was linked to decades of using Johnson & Johnson's baby powder.
In the latest lawsuit, Gloria Ristesund blamed her ovarian cancer on years of talcum powder use.
Her attorney, Jim Onder, said Johnson & Johnson knew about the "dangers associated with talcum powder for over 30 years".
"Instead of giving a warning, what they did was target the groups most at risk for developing ovarian cancer," he said.
Johnson & Johnson said it will appeal the latest ruling.
In a statement, a spokeswoman for the firm said the verdict "goes against 30 years of studies by medical experts around the world that continue to support the safety of cosmetic talc".
"For over 100 years, Johnson & Johnson has provided consumers with a safe choice for cosmetic powder products and we will continue to work hard to exceed consumer expectations and evolving product preferences," Carol Goodrich said.
The company is facing some 1,200 similar lawsuits.
The suits allege that the health products firm actively covered up studies that suggested a link between ovarian cancer and their baby powder in order to boost sales.
In 2011, Johnson & Johnson vowed to remove "chemicals of concern" from its baby products, the AP news agency reported. It said its adult products would be reformulated by 2016.
No comments:
Post a Comment